Roy F Chemaly1, Raymund Dantes2, Dimpy P Shah1, Pankil K Shah3, Neil Pascoe4, Ella Ariza-Heredia1, Cheryl Perego1, Duc B Nguyen2, Kim Nguyen1, Farhad Modarai5, Heather Moulton-Meissner5, Judith Noble-Wang5, Jeffrey J Tarrand6, John J LiPuma7, Alice Y Guh5, Tara MacCannell5, Issam Raad1, Victor Mulanovich1. 1. Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston. 2. Epidemic Intelligence Service, Scientific Education and Professional Development Program Office Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. The University of Texas School of Public Health, Houston. 4. Texas Department of State Health Services, Austin. 5. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 6. Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston. 7. Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor.
Abstract
BACKGROUND: Herbaspirillum species are gram-negative Betaproteobacteria that inhabit the rhizosphere. We investigated a potential cluster of hospital-based Herbaspirillum species infections. METHODS: Cases were defined as Herbaspirillum species isolated from a patient in our comprehensive cancer center between 1 January 2006 and 15 October 2013. Case finding was performed by reviewing isolates initially identified as Burkholderia cepacia susceptible to all antibiotics tested, and 16S ribosomal DNA sequencing of available isolates to confirm their identity. Pulsed-field gel electrophoresis (PFGE) was performed to test genetic relatedness. Facility observations, infection prevention assessments, and environmental sampling were performed to investigate potential sources of Herbaspirillum species. RESULTS: Eight cases of Herbaspirillum species were identified. Isolates from the first 5 clustered cases were initially misidentified as B. cepacia, and available isolates from 4 of these cases were indistinguishable. The 3 subsequent cases were identified by prospective surveillance and had different PFGE patterns. All but 1 case-patient had bloodstream infections, and 6 presented with sepsis. Underlying diagnoses included solid tumors (3), leukemia (3), lymphoma (1), and aplastic anemia (1). Herbaspirillum species infections were hospital-onset in 5 patients and community-onset in 3. All symptomatic patients were treated with intravenous antibiotics, and their infections resolved. No environmental source or common mechanism of acquisition was identified. CONCLUSIONS: This is the first report of a hospital-based cluster of Herbaspirillum species infections. Herbaspirillum species are capable of causing bacteremia and sepsis in immunocompromised patients. Herbaspirillum species can be misidentified as Burkholderia cepacia by commercially available microbial identification systems.
BACKGROUND: Herbaspirillum species are gram-negative Betaproteobacteria that inhabit the rhizosphere. We investigated a potential cluster of hospital-based Herbaspirillum species infections. METHODS: Cases were defined as Herbaspirillum species isolated from a patient in our comprehensive cancer center between 1 January 2006 and 15 October 2013. Case finding was performed by reviewing isolates initially identified as Burkholderia cepacia susceptible to all antibiotics tested, and 16S ribosomal DNA sequencing of available isolates to confirm their identity. Pulsed-field gel electrophoresis (PFGE) was performed to test genetic relatedness. Facility observations, infection prevention assessments, and environmental sampling were performed to investigate potential sources of Herbaspirillum species. RESULTS: Eight cases of Herbaspirillum species were identified. Isolates from the first 5 clustered cases were initially misidentified as B. cepacia, and available isolates from 4 of these cases were indistinguishable. The 3 subsequent cases were identified by prospective surveillance and had different PFGE patterns. All but 1 case-patient had bloodstream infections, and 6 presented with sepsis. Underlying diagnoses included solid tumors (3), leukemia (3), lymphoma (1), and aplastic anemia (1). Herbaspirillum species infections were hospital-onset in 5 patients and community-onset in 3. All symptomatic patients were treated with intravenous antibiotics, and their infections resolved. No environmental source or common mechanism of acquisition was identified. CONCLUSIONS: This is the first report of a hospital-based cluster of Herbaspirillum species infections. Herbaspirillum species are capable of causing bacteremia and sepsis in immunocompromised patients. Herbaspirillum species can be misidentified as Burkholderia cepacia by commercially available microbial identification systems.
Authors: Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren Journal: Clin Infect Dis Date: 2009-07-01 Impact factor: 9.079
Authors: J I Baldani; B Pot; G Kirchhof; E Falsen; V L Baldani; F L Olivares; B Hoste; K Kersters; A Hartmann; M Gillis; J Döbereiner Journal: Int J Syst Bacteriol Date: 1996-07
Authors: J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme Journal: J Clin Microbiol Date: 1999-10 Impact factor: 5.948
Authors: Preeta K Kutty; Barbara Moody; Jessica Smartt Gullion; Marcus Zervos; Marie Ajluni; Rebecca Washburn; Roger Sanderson; Marion A Kainer; Timothy A Powell; Carmen F Clarke; Renee J Powell; Neil Pascoe; Alicia Shams; John J LiPuma; Bette Jensen; Judith Noble-Wang; Matthew J Arduino; L Clifford McDonald Journal: Chest Date: 2007-10-09 Impact factor: 9.410
Authors: Theodore Spilker; Ahmet Z Uluer; Francisco M Marty; Wendy W Yeh; Julie H Levison; Peter Vandamme; John J Lipuma Journal: J Clin Microbiol Date: 2008-06-04 Impact factor: 5.948
Authors: I Bloise; G V Guedez-López; M Tejedor-Rodríguez; M P Romero-Gómez; J García-Rodríguez; J Mingorance; E Cendejas-Bueno Journal: Eur J Clin Microbiol Infect Dis Date: 2020-10-21 Impact factor: 3.267